INS and type 1 diabetes mellitus: The current therapeutic approach for the treatment of T1D may increase the risk of complications including hypoglycemia (in case of insulin injections) and immunosuppression (in case of the chronic use of immunosuppressive drugs to maintain transplanted pancreas and/or islets) (Hirshberg et al., 2003; Kolb et al., 2020).